Atlas Trials

Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients

Clinical trial NCT03344627 · COMPLETED

Trial details

NCT number
NCT03344627
Sponsor
Mahidol University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
SepsisSeptic ShockCritical IllnessCarbapenemPharmacokineticPharmacodynamicClinical OutcomeOrgan Failure, MultipleMorality
Start date
2017-11-27
Primary completion
2018-11-30
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.